Bristol Myers Squibb is set to showcase new clinical and real-world findings on Camzyos (mavacamten) for obstructive and non-obstructive hypertrophic cardiomyopathy at the ESC Congress 2025. The presentations include data from the global COLLIGO-HCM study, a pooled Phase 3 monotherapy analysis, and highlights from the largest trial to date in non-obstructive HCM.

One family’s painful loss has sparked deeper questions about changing vaccine guidance. With concern mounting over advice that suggests some groups “do not need” COVID-19 shots, the nation faces a moral and public health crossroads.

A large study out of Karolinska Institutet suggests that people who’ve had COVID-19 could be at a higher risk of developing asthma, sinusitis, and hay fever. Researchers note vaccination appears to reduce these heightened chances.

A dedicated group of women in Dallas is set to take the football field to raise funds and awareness for Alzheimer’s disease. Founded by sisters who experienced the disease in their own family, BVB Dallas has already raised over $6.5 million for Alzheimer’s research and aims to reach $300,000 more this year.

Serena Williams has confirmed she joined the growing ranks of individuals using GLP-1 medication for weight loss. The 43-year-old tennis icon discussed her decision following her struggle to drop pounds after childbirth.

A South Lake Tahoe resident has recovered from a rare plague infection reportedly contracted through a flea bite during a camping trip. Health officials are reminding everyone to take basic precautions against rodent and flea exposure to prevent future cases.

A Missouri patient has died after contracting a “brain-eating amoeba,” an infection linked to water skiing at Lake of the Ozarks. Health officials confirm the case is part of a 97% fatal condition that underscores the importance of understanding potential freshwater risks.

A new malaria treatment, recently approved by Swiss medical regulators, offers fresh optimism to health workers caring for infants in Uganda. As malaria continues to threaten lives across Africa, this landmark decision could pave the way for better protection of the most vulnerable.

New Jersey health and environmental officials are investigating what could be the state’s first locally acquired malaria infection in more than 30 years. The patient, a Morris County resident who has not traveled, has prompted authorities to determine how the disease appeared so close to home.

Viking Therapeutics unveiled Phase 2 results for its once-daily obesity pill, VK2735, showing up to 12.2 percent average weight loss after 13 weeks. Yet investors punished the stock, a reaction one analyst dismissed as “extreme,” underscoring the fierce competition from Eli Lilly’s tirzepatide.

After a decade and a half without fresh therapeutic options, fibromyalgia patients finally have reason for optimism. The FDA’s approval of Tonmya is the first new treatment for the condition in 15 years, promising more effective pain relief and a better quality of life.

Skin allergies are common and often frustrating to diagnose. But new technology could soon help change that. Emerging advances, including artificial intelligence, promise a more efficient future in allergy testing.

As COVID-19 cases begin to rise again in Hawaii, health officials are calling on the public to remain vigilant to prevent further spread of the virus. The resurgence has prompted a renewed emphasis on caution among residents and visitors alike.

Recent reports have raised concerns about a potential link between commonly used medications and an increased risk of dementia. Antacids, in particular, have been highlighted as possible contributors to cognitive decline. Health experts are urging the public to be cautious and informed about the medications they use.

Xeltis has announced positive preliminary data from its ongoing EU clinical trial of the Xabg coronary artery bypass conduit. The study evaluates the technology in patients with multi-vessel coronary artery disease scheduled for elective bypass surgery.

The ESPYS celebrated outstanding athletic achievements and profound stories of resilience, with Shai Gilgeous-Alexander and Simone Biles receiving top honors, and Katie Schumacher-Cawley’s heartfelt acceptance of the Jimmy V Award capturing the audience’s admiration.

New research uncovers how prophages prevent superinfection by blocking bacterial cell surface receptors, ensuring the survival of their viral progeny.

Women experiencing premature ovarian insufficiency face significantly higher risks of depression and anxiety. Experts are now calling for routine mental health screenings to support those affected by early menopause.

A confirmed measles case in an eastern Iowa adult has raised potential exposure concerns in Dubuque, according to state health officials.

Researchers have discovered a novel way to retrain neutrophils—the body’s first responders—to directly attack aggressive breast cancer cells, offering new hope to patients unresponsive to current immunotherapies.

Just a week before groundbreaking HIV vaccine trials were set to begin, South African scientists received an email halting their efforts—aid cuts had struck a devastating blow to critical research.